Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
about
Diagnosis of lyme borreliosis.Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritisThe Past, Present, and (Possible) Future of Serologic Testing for Lyme DiseaseLyme disease: the promise of Big Data, companion diagnostics and precision medicineIdentification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmidsThe Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early lyme disease is the flaA gene product.Population-based study of diagnostic assays for Borrelia infection: comparison of purified flagella antigen assay (Ideia, Dako Cytomation) and recombinant antigen assay (Liaison, DiaSorin).Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitopeDiagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis.Fitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field.Is there a Lyme-like disease in Australia? Summary of the findings to dateExpression of the bmpB gene of Borrelia burgdorferi is modulated by two distinct transcription termination eventsTransformation of the Lyme disease spirochete Borrelia burgdorferi with heterologous DNA.Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions.Lyme Disease Serology.Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine.Effects of OspA vaccination on Lyme disease serologic testing.Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.Borrelia burgdorferi B31 Erp proteins that are dominant immunoblot antigens of animals infected with isolate B31 are recognized by only a subset of human lyme disease patient sera.Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigensA European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis.Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferiEvaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosisEvaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccinationComparison of immunodot and western blot assays for diagnosing Lyme borreliosis.Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.Lyme disease, Virginia, USA, 2000-2011OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients.Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis.ospC diversity in Borrelia burgdorferi: different hosts are different niches.Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto.Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle.Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferiOuter surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspCOuter surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro.Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31.
P2860
Q22242237-AEA85ED7-6693-4D68-8267-1488D4E9C358Q24682073-ED6BEBD7-2402-4693-8F10-74867587DBD1Q28075680-30E35F09-04B3-4A2D-839C-94D67B080CDEQ28830150-6631A414-6A18-44CB-BFE1-75592719D4D8Q30964822-E597A9D0-3C88-433C-A6CA-6970A0C7B7DFQ31906497-3BEE96D0-FECA-4113-888D-8BA06223F65FQ33329260-857B797B-188E-4FC3-9532-F9C4C6CB752CQ33601926-4D0E7C18-4286-424B-A3BC-A9BBC907B68BQ33662007-EF221975-DB28-4540-AAD2-049F3AC74E8FQ33683043-CF7325DA-0A3E-4393-BF3E-53CC4284EB08Q33686914-8964F415-FDDE-4A33-B372-9B8C943D941CQ33718333-11E70DF8-FFE7-4E3A-8D3F-B78D77FCCC0FQ33726791-D0D70095-6B00-44E7-8A7F-75ADDB21DCBEQ33737000-411BB373-B14F-47A2-9D02-BDDCF31F9D24Q33828584-4C4F78EF-F8A3-41FF-9EF4-F2A139593A76Q33853982-C23609F8-29EC-442F-A1F8-A498DFFFA97CQ33962743-0D586C7C-96F5-4647-8F15-908A3E438D22Q33963736-ADD9D32F-9E42-433C-B736-D20481C936F7Q33964217-956DE416-C413-40D7-A422-B04D848D70C7Q33966524-5735974A-558D-4655-8EA9-E98A67B9BD9DQ33966777-6E6332CF-0D5B-459C-BA59-5F64DCD4A7F9Q33967326-AA28D25B-1933-4CF0-8A5F-B713117EE7AEQ33973394-50782E5B-EB5E-48DB-B65A-9448F42C78F1Q33973449-E9AC3DCB-D670-4D99-B9B1-35462B62C627Q33974847-9D0C3189-21AA-49EA-BB97-6DDCF27E37FCQ33997348-BE8B9A14-1B8E-4784-AE21-7661373418C5Q34009665-20E239E7-3717-4A0F-A7FE-BFD6E514A5FFQ34045483-368F5C81-5BA6-4BBD-9095-C0153A4CC10CQ34320888-7586505D-094F-48F2-990A-1A68F9E66FC1Q34439525-CF6014D2-47C4-45ED-B461-748447A3959AQ34453998-4EC39646-320E-4F21-9548-8A1BA9BE13E4Q34569887-91A182DB-39B7-45B2-B82A-4704A73D5BC5Q34606054-2763310C-8F6D-4CC6-A8B9-CF25D520C4B2Q34945715-2A4D7231-93D6-44E8-95A7-3C5DD3B5F7ACQ35066161-493A6921-E051-4A23-9657-B32A72B33201Q35227056-51144E7B-F9E0-4199-B3AE-9109BD0CE260Q35452406-A661C3CA-B23E-4E31-BAD8-8963F9C369C3Q35499316-E233FA21-CA5B-4B61-B93E-33150067039FQ35511753-B941E7B8-1122-4B27-8F5F-CF8E1C6473FFQ35519913-CC387B60-BE3F-4C7C-BA14-143CDE74E52D
P2860
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@ast
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@en
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@nl
type
label
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@ast
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@en
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@nl
prefLabel
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@ast
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@en
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@nl
P2093
P2860
P3181
P1476
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
@en
P2093
R C Johnson
S M Engstrom
P2860
P304
P3181
P407
P577
1995-02-01T00:00:00Z